TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/18 15:21 | 1/10/18 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Katz Richard D | NC | O | VP,CFO | S.a | -17 | 0.1647 | 0 | -104 | -35 | 194 | D | ||||||||||||||
1/12/18 13:41 | 1/9/18 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Katz Richard D | NC | O | VP,CFO | S | -17 | 0.1647 | 0 | -104 | -35 | 194 | D | ||||||||||||||
1/5/18 12:12 | 1/3/18 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Katz Richard D | NC | O | VP,CFO | S | -17 | 0.1634 | 0 | -101 | -25 | 298 | D | ||||||||||||||
8/22/11 15:07 | 8/18/11 | ICGN | Icagen Inc | DE | Health | Drug | Pharmaceutical Preparations | Katz Richard D | NC | O | Ex VP,Fi | S | 0 | 5.96 | 0 | 0 | 0 | 76 | D | ||||||||||||||
8/12/11 17:07 | 8/10/11 | ICGN | Icagen Inc | DE | Health | Drug | Pharmaceutical Preparations | Katz Richard D | NC | O | Ex VP,Fi | S | 0 | 5.96 | 0 | 0 | 0 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |